PMID- 33661042 OWN - NLM STAT- MEDLINE DCOM- 20220103 LR - 20220103 IS - 1557-7732 (Electronic) IS - 1080-7683 (Linking) VI - 37 IP - 5 DP - 2021 Jun TI - Neurotrophic Factors Secreted by Induced Pluripotent Stem Cell-Derived Retinal Progenitors Promote Retinal Survival and Preservation in an Adult Porcine Neuroretina Model. PG - 301-312 LID - 10.1089/jop.2020.0088 [doi] AB - Purpose: Paracrine factors released by pluripotent stem cells have shown great potential as therapeutic agents in regenerative medicine. The purpose of this study was to characterize trophic factor secretion of retinal progenitor cells (RPCs) derived from human induced pluripotent stem cells (iPSCs) and to assess its impact on retinal survival ex vivo. Methods: RPCs were generated from human 3D1 iPSCs following previously established protocols with modifications. Conditioned medium (CM) was harvested from iPSC-derived retinal progenitors and analyzed for trophic factor composition through multiplex enzyme-linked immunosorbent assay. Retina-preserving capability of the collected CM was examined using a degenerative porcine neuroretina model. Viability of the CM-treated retina explants was evaluated using the resazurin-based PrestoBlue reagent, whereas the lactate dehydrogenase (LDH) assay was used to assess retinal cytotoxicity. Retina explants were also analyzed morphologically through immunohistochemistry for glial cell activation and apoptosis. Results: We have successfully generated and characterized iPSC-derived RPCs that secreted an array of neuroprotective factors, including osteopontin, hepatocyte growth factor, stromal cell-derived factor 1, and insulin-like growth factor-1. Retina explants cultured in CM derived from iPSC-RPCs (iPSC-RPC-CM) showed better preservation of the retinal microarchitecture and fewer terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL)(+) nuclei, and reduced reactive gliosis. Furthermore, we saw a reduction in extracellular LDH levels in CM-treated retina explants, which also exhibited higher metabolic activity than the untreated controls. Conclusions: iPSC-derived RPCs secrete many trophic factors that have been shown to promote neuroprotection, tissue repair, and regeneration in the retina. Overall, we have demonstrated the neuroprotective effects of iPSC-RPC-CM through a degenerative neuroretina model ex vivo. FAU - Rettinger, Christina L AU - Rettinger CL AD - Ocular and Sensory Trauma Task Area, United States Army Institute of Surgical Research, Fort Sam Houston, Texas, USA. FAU - Kaini, Ramesh R AU - Kaini RR AD - Ocular and Sensory Trauma Task Area, United States Army Institute of Surgical Research, Fort Sam Houston, Texas, USA. FAU - Burke, Teresa A AU - Burke TA AD - Ocular and Sensory Trauma Task Area, United States Army Institute of Surgical Research, Fort Sam Houston, Texas, USA. FAU - Wang, Heuy-Ching AU - Wang HC AD - Ocular and Sensory Trauma Task Area, United States Army Institute of Surgical Research, Fort Sam Houston, Texas, USA. LA - eng PT - Journal Article DEP - 20210303 PL - United States TA - J Ocul Pharmacol Ther JT - Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics JID - 9511091 RN - 0 (Nerve Growth Factors) RN - 0 (Neuroprotective Agents) RN - EC 1.1.1.27 (L-Lactate Dehydrogenase) SB - IM MH - Adult MH - Animals MH - Apoptosis MH - Cell Survival MH - Enzyme-Linked Immunosorbent Assay/methods MH - Female MH - Humans MH - Immunohistochemistry/methods MH - Induced Pluripotent Stem Cells/*metabolism/transplantation MH - L-Lactate Dehydrogenase/drug effects/metabolism MH - Models, Animal MH - Nerve Growth Factors/*pharmacology MH - Neuroglia/drug effects/pathology MH - Neuroprotective Agents/*pharmacology MH - Regenerative Medicine/statistics & numerical data MH - Retina/*drug effects/embryology/pathology/ultrastructure MH - Stem Cells/metabolism MH - Swine OTO - NOTNLM OT - human iPSCs OT - neuroprotection OT - porcine retina explants OT - retinal progenitor cells OT - retinal survival EDAT- 2021/03/05 06:00 MHDA- 2022/01/04 06:00 CRDT- 2021/03/04 12:11 PHST- 2021/03/05 06:00 [pubmed] PHST- 2022/01/04 06:00 [medline] PHST- 2021/03/04 12:11 [entrez] AID - 10.1089/jop.2020.0088 [doi] PST - ppublish SO - J Ocul Pharmacol Ther. 2021 Jun;37(5):301-312. doi: 10.1089/jop.2020.0088. Epub 2021 Mar 3.